Technical Analysis for PTCT - PTC Therapeutics, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 24.69 | -1.87% | -0.47 |
Earnings due: Apr 25
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Lower Bollinger Band Walk | Weakness | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
Down 5 Days in a Row | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
NR7 | Range Contraction | -1.87% | |
Lower Bollinger Band Walk | Weakness | -1.87% | |
Down 3 Days in a Row | Weakness | -1.87% | |
Down 4 Days in a Row | Weakness | -1.87% |
Alert | Time |
---|---|
Lower Bollinger Band Support | about 14 hours ago |
Fell Below Lower Bollinger Band | about 15 hours ago |
Down 2 % | about 15 hours ago |
Fell Below Previous Day's Low | about 15 hours ago |
Down 1% | about 15 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 04/25/2024
PTC Therapeutics, Inc. Description
PTC Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orally administered and proprietary small-molecule drugs for patients living with serious and life-threatening conditions, including genetic and neuromuscular disorders, cancer, and infectious diseases. Its approach includes post-transcriptional control, RNA biology, and gene expression modulation by small-molecules. The company has strategic alliances with AstraZeneca; Celgene Corporation; Cystic Fibrosis Foundation; Genzyme Corporation; Gilead; Muscular Dystrophy Association; Merck & Co., Inc.; Parent Project Muscular Dystrophy; Pfizer Inc.; Roche; Spinal Muscular Atrophy Foundation; and Wellcome Trust. PTC Therapeutics, Inc. was founded in 1998 and is based in South Plainfield, New Jersey.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Biology Infectious Diseases Neurological Disorders Dystrophy Gene Expression Muscular Dystrophy Cystic Fibrosis Neurodegenerative Disorders Transcription Spinal Muscular Atrophy Genzyme Neuromuscular Disorders
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 59.75 |
52 Week Low | 17.53 |
Average Volume | 815,464 |
200-Day Moving Average | 29.14 |
50-Day Moving Average | 27.99 |
20-Day Moving Average | 27.57 |
10-Day Moving Average | 26.31 |
Average True Range | 1.34 |
RSI (14) | 33.77 |
ADX | 22.79 |
+DI | 10.45 |
-DI | 23.60 |
Chandelier Exit (Long, 3 ATRs) | 26.93 |
Chandelier Exit (Short, 3 ATRs) | 28.49 |
Upper Bollinger Bands | 30.61 |
Lower Bollinger Band | 24.54 |
Percent B (%b) | 0.02 |
BandWidth | 21.99 |
MACD Line | -0.96 |
MACD Signal Line | -0.59 |
MACD Histogram | -0.3711 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 25.91 | ||||
Resistance 3 (R3) | 25.97 | 25.62 | 25.70 | ||
Resistance 2 (R2) | 25.62 | 25.31 | 25.59 | 25.63 | |
Resistance 1 (R1) | 25.16 | 25.12 | 24.99 | 25.10 | 25.57 |
Pivot Point | 24.81 | 24.81 | 24.73 | 24.78 | 24.81 |
Support 1 (S1) | 24.35 | 24.50 | 24.18 | 24.29 | 23.81 |
Support 2 (S2) | 24.00 | 24.31 | 23.97 | 23.75 | |
Support 3 (S3) | 23.54 | 24.00 | 23.68 | ||
Support 4 (S4) | 23.48 |